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ttp://dx.doi.org/10.1016/j.ajpath.2015.12.014Recreational abuse of ketamine has been associated with the emergence of a new bladder pain syndrome,
ketamine-induced cystitis, characterized by chronic inﬂammation and urothelial ulceration. We investigated
the direct effects of ketamine on normal human urothelium maintained in organ culture or as ﬁnite cell lines
in vitro. Exposure of urothelium to ketamine resulted in apoptosis, with cytochrome c release from mito-
chondria and signiﬁcant subsequent caspase 9 and 3/7 activation. The anesthetic mode-of-action for ke-
tamine is mediated primarily through N-methyl D-aspartate receptor (NMDAR) antagonism; however, normal
(nonimmortalized) human urothelial cells were unresponsive to NMDAR agonists or antagonists, and no
expression of NMDAR transcript was detected. Exposure to noncytotoxic concentrations of ketamine (1
mmol/L) induced rapid release of ATP, which activated purinergic P2Y receptors and stimulated the inositol
trisphosphate receptor to provoke transient release of calcium from the endoplasmic reticulum into the
cytosol. Ketamine concentrations >1 mmol/L were cytotoxic and provoked a larger-amplitude increase in
cytosolic Ca2þ concentration that was unresolved. The sustained elevation in cytosolic Ca2þ concentration
was associated with pathological mitochondrial oxygen consumption and ATP deﬁciency. Damage to the
urinary barrier initiates bladder pain and, in ketamine-induced cystitis, loss of urothelium from large areas of
the bladder wall is a reported feature. This study offers ﬁrst evidence for a mechanism of direct toxicity
of ketamine to urothelial cells by activating the intrinsic apoptotic pathway. (Am J Pathol 2016, 186:
1267e1277; http://dx.doi.org/10.1016/j.ajpath.2015.12.014)Supported by Wellcome Trust award 092430/Z/10/Z (S.C.B.), Wellcome
Trust grant 090577/Z/09/Z (J.S. and S.S.), and York Against Cancer
research chair (J.S.), and supported in part by the Wellcome Trust (105624)
through the Centre for Chronic Diseases and Disorders (C2D2) at the
University of York.
Disclosures: None declared.The phencyclidine derivative ketamine is an N-methyl-D-
aspartate (NMDA) receptor antagonist,1 which is used as a
rapid-onset, short-duration anesthetic and analgesic in clin-
ical and veterinary practice. In the clinical setting, ketamine
is particularly used as an anesthetic in pediatric and asth-
matic cases, and for palliative care. Recreational use of
ketamine, which has been increasing since the 1980s, is
based around its phencyclidine-like effects, whereby it in-
duces hallucinations, stimulates out-of-body experiences,
and increases empathy and insight.2
The emergence of upper and lower urinary tract damage
resulting from ketamine abuse was reported originally as case
studies in 2007, where symptoms of urinary frequency/urgency,stigative Pathology. Published by Elsevier Inc
Y license (http://creativecommons.org/licensesnocturia, hematuria, and suprapubic pain were accompanied by
a thickened, contracted, and inﬂamed bladder.3,4
The sloughing of the bladder epithelium (urothelium)
observed by histology in ketamine cystitis patients is suggestive
of a direct toxicity against the urothelium,5 but no mechanism
has yet been established. Ketamine has been classiﬁed as an
N-methyl D-aspartate receptor (NMDAR) antagonist,1 and.
/by/4.0).
Baker et alin vitro studies with cortical neurons from rats6 and monkeys7
have identiﬁed the NMDAR as a mediator of ketamine-
induced apoptosis. NMDAR subunits have been reported to
be expressed in the urinary tract of rats,8 which suggests this as a
potential mechanism in human urothelium. Our aim was to
identify a mechanism for the direct toxicity of ketamine on
normal (nonimmortalized) human urothelial (NHU) cells to
enhance understanding of the clinical pathology.
Materials and Methods
Chemicals and Reagents
Racemic ketamine hydrochloride salt (without preservatives)
was soluble in cell culture medium at 10 mmol/L and was
0.2 mm ﬁlter-sterilized before use. Unless speciﬁed otherwise,
all chemicals were of analytical or tissue culture grade, as
appropriate, and were obtained from Sigma-Aldrich Company
Ltd. (Gillingham, UK).
Because of the high concentrations of ketamine used in
this study (and recreationally), it was important to assess the
effects of ketamine (0.1 to 10 mmol/L) on the osmolality of
culture medium. No change in osmolality of complete
keratinocyte serum-free medium (KSFMc) was observed at
ketamine concentrations <5 mmol/L, and although slight
increases were recorded at 5 mmol/L and greater, the con-
centrations used in this study did not exceed the normal
osmolality range of serum (275 to 299 mOsm/kg).
Urothelial Cell Isolation and Culture
Urothelium was collected with National Health Service
Research Ethics Committee approval and required informed
consent from urological procedures that excluded urothelial
neoplasia. Finite (nonimmortal, serially passaged) NHU cell
lines were established inKSFMc (Invitrogen, Paisley, UK)with
cholera toxin, as described previously.9 For this study, cell lines
derived from eight individuals were used up to passage 5.
Cell counts were performed using Trypan Blue exclusion to
identify viable cells using an improved Neubauer Hemo-
cytometer (SLS, Wilford, UK). To eliminate cyclic-adenosine
monophosphate as a confounding factor, all experiments were
performed in KSFMc without cholera toxin.
Organ cultures were established from human ureteric
tissue and maintained in Dulbecco’s modiﬁed Eagle’s
medium/RPMI 1640 medium (50:50 mix) supplemented
with 5% fetal bovine serum. After 72 hours’ exposure to
3 mmol/L ketamine, ureteric organ cultures from six do-
nors were ﬁxed in 10% formalin for 24 hours, dehydrated
through graded alcohols, and embedded in parafﬁn wax for
histological evaluation.
Histological Evaluation of Organ Cultures
Dewaxed tissue sections (5 mm thick) were either stained with
hematoxylin and eosin (following standard methods) or1268immunoperoxidase-labeled using the M30 Cytodeath anti-
body to cleaved cytokeratin 18 (Roche,Mannheim, Germany).
For immunoperoxidase labeling, blocking steps were
included to neutralize endogenous peroxidase and avidin-
binding activities. Heat-mediated antigen retrieval was
performed by microwave boiling for 10 minutes in
10 mmol/L citric acid buffer (pH 6). After overnight incu-
bation in primary antibody (diluted 1:100) at 4C, slides
were washed, incubated in biotinylated secondary anti-
bodies and a streptavidin-biotin horseradish peroxidase
complex (Dako Cytomation, Ely, UK), and visualized using
a diaminobenzidine substrate reaction. Sections were
counterstained with hematoxylin, dehydrated, and mounted
in DPX (CellPath, Powys, UK).
Quantiﬁcation of Cell Number by Alamar Blue Assay
Alamar Blue (AbD Serotec, Kidlington, UK), diluted 1:10 with
KSFMc, was added to cells grown in 96-well plates. After 4
hours’ incubation at 37C, the absorbance was measured at 570
and 630 nm. The reduction of the Alamar Blue dye is propor-
tional to mitochondrial enzyme activity and can be used as a
proxy for viable cell number.10
Calcium Imaging
NHU cells were seeded at 5  104 cells/cm2 onto collagen-
coated (0.1 mg/mL rat-tail collagen; Becton Dickinson,
Oxford, UK) glass coverslips and maintained for 24 hours.
Before imaging, cultures were washed with HEPES-buffered
saline solution (HBSS; 138 mmol/L NaCl, 5 mmol/L KCl,
0.3 mmol/L KH2PO4, 4 mmol/L NaHCO3, 0.3 mmol/L
NaHPO4, 1 mmol/L MgCl2, 2 mmol/L CaCl2, and 10 mmol/L
HEPES, pH 7.4) and then loaded with 5 mmol/L ﬂuo-4(AM)
and 5 mmol/L fura-red(AM) in HBSS with 0.02% pluronic
acid for 25minutes. Cultures werewashed twice inHBSS, and
the coverslips were placed in a perfusion chamber (Warner
Instruments, supplied byHarvard Apparatus Ltd., Edenbridge,
UK) on the stage of a Revolution XD spinning disk confocal
microscope (Andor, Belfast, UK). The chamber was perfused
with an automated pump (Scientiﬁca, Uckﬁeld, UK) at a ﬂow
rate of 1.5 mL/minute, and images were recorded at a rate of
1/second.
In some experiments, to differentiate exogenous from
intrinsic calcium stores, cells were preincubated for
10 minutes in calcium-free HBSS (138 mmol/L NaCl,
5 mmol/L KCl, 0.3 mmol/L KH2PO4, 4 mmol/L NaHCO3,
0.3 mmol/L NaHPO4, 1 mmol/LMgCl2, 5 mmol/L EGTA, and
10 mmol/L HEPES, pH 7.4), and experiments were performed
in the calcium-free buffer.
Changes in the intensity of the fura-red and ﬂuo-4 ﬂuo-
rescent signal were measured in all of the cells in the ﬁeld of
view using Andor iQ software version 2.1 (Andor, Belfast,
UK), which was used to record and export raw data over
time. The data were imported in Origin 8.6 (Origin Labs,
Microcal, Stoke Mandeville, UK), and the ratio ofajp.amjpathol.org - The American Journal of Pathology
Figure 1 Histological assessment of human ureteric organ cultures after
72 hours’ exposure to 3 mmol/L ketamine showed thinning of the epithelium
(shown in the images of donor x) and clear signs of apoptosis, including
pyknotic nuclei and karyorrhexis (shown in the images of donor y). Immu-
noreactivity with a cleaved cytokeratin 18 antibody (M30 Cytodeath) was
observed in cells being lost from the epithelium (arrows). nZ 6 donors with
two representative examples shown. Scale barZ 100 mm. H&E, hematoxylin
and eosin.
Figure 2 Effects of ketamine on population growth in cultures of normal
(nonimmortalized) human urothelial (NHU) cells. A: Concentrations of keta-
mine between 0.3 and 6 mmol/L were assessed during a 6-day time course by
Alamar Blue reduction assay. This graph is representative of repeats in three
independent donor cell lines. B: Counts from two donor cell lines after 96
hours of exposure to ketamine indicated a half maximal inhibitory concen-
tration (IC50) for NHU cells of 0.93 mmol/L. The IC50 was calculated using a
sigmoidal ﬁt and is illustrated as a solid black line; the 95% CI is shown as
dashed lines. Error bars represent SD (A). n Z 6 (A); n Z 4 replicates per
donor (B).
Ketamine-Induced Apoptosis in Urotheliumﬂuorescence was calculated to indicate the change in
intracellular Ca2þ concentration.
RT-PCR
RNA was extracted in Trizol reagent (Thermo Fisher Sci-
entiﬁc, Loughborough, UK), any contaminating DNA was
digested using a DNA-free kit (Thermo Fisher Scientiﬁc),
and cDNA was synthesized using Oligo(dT) 12-18 primers
(Invitrogen). RT-PCR was performed using SureStart Taq
polymerase (Agilent Technologies LDA UK Ltd., Stockport,
UK) and a thermal cycler (PCR Express; Hybaid, Thermo
Fisher Scientiﬁc). With the following annealing tempera-
tures, primers were designed to amplify GRIN1 (forward, 50-
GCATCCTCGGGCTGCAGCTC-30 and reverse, 50-AGC-
GGCCCGGTCTTCCAGAT-30, 61C), GRIN2A (forward,
50-GTGGTCTATCAACGGGCAGT-30 and reverse, 50-AG-
GTGAGACGGTGCCATTAC-30, 51C), GRIN2B (forward,The American Journal of Pathology - ajp.amjpathol.org50-GATGGGAGCCCCTACGCCCA-30 and reverse, 50-CC-
ACCGTGGGCTGCCTGAAG-30, 60C), GRIN2C (forward,
50-CGACGCCAGCCACGTGAGTT-30 and reverse, 50-AG-
AGCACCTCGGCCTCCTCG-30, 54C, with 5% dimethyl
sulfoxide added to the reaction), GRIN2D (forward, 50-CC-
ACCTTCCTGCAGCTGGGC-30 and reverse, 50-GAGCTG-
GGCACTGAGCACGG-30, 61C), glyceraldehyde-3-phosphate
dehydrogenase (forward, 50-ACCCAGAAGACTGTGGAT-
GG-30 and reverse, 50-TTCTAGACGGCAGGTCAGGT-30,
60C), and UPK2 (forward, 50-CTCCCGCAAGTAAGGA-
GGT-30 and reverse, 50-GAAGGATGGGGGAATTGTTA-30,
58C) transcripts. Reverse transcription negative controls were
included in all experiments.1269
Figure 3 Induction of apoptosis in normal
(nonimmortalized) human urothelial (NHU) cell cul-
tures by ketamine. A: Western blot analysis of NHU
cells separated into cytoplasmic and mitochondrial
fractions showed elevated cytochrome c in the
cytosolic fractions of cultures treated with 3 mmol/L
ketamine for 24 hours. Loading controls were Bcl2
for the mitochondrial fraction and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) for the cyto-
plasmic fraction. B: Densitometry analysis showed a
signiﬁcant mean 2.4-fold change in cytoplasmic cy-
tochrome c content in three independent NHU cell
lines after 24 hours’ exposure to 3 mmol/L ketamine.
C: Western blot analysis of phospho-Akt (active
form), phospho-ERK1/2 (active form), and S9
phospho-glycogen synthase kinase (GSK) 3b (inac-
tive form) showed early depletion of these forms of
the kinases in response to 3 mmol/L ketamine.
Abundance quantiﬁed by densitometry is shown as a
percentage of control cells for each time point,
normalized to b-actin (combined data). D: Inhibition
of GSK3b by SB415286 in ketamine-exposed NHU
cells was capable of a slight, but signiﬁcant, inhibi-
tion of toxicity, as assessed by Alamar Blue reduc-
tion. E: Inhibition of the mitochondrial permeability
transition pore with cyclosporin A (CsA) in ketamine-
exposed NHU cells was capable of a small, but sig-
niﬁcant, inhibition of toxicity, as assessed by Alamar
Blue reduction. F: Western blot analysis of caspase 9,
caspase 3, and cleaved poly (ADP-ribose) polymerase
(PARP) in NHU cells after 72 hours’ exposure to 3
mmol/L ketamine. G: The three markers of apoptosis
were all signiﬁcantly increased by more than twofold
in densitometry, which was normalized to b-actin. H:
Caspase 3/7 activity was assessed in lysates from
NHU cell cultures exposed to 0.1 to 6 mmol/L ke-
tamine and normalized to baseline caspase activity
in untreated cells. Signiﬁcant increases in caspase
activity were observed after exposure to 3 and 6
mmol/L ketamine. Error bars represent SD (B, D, E,
G, and H). nZ 4 donors (C); nZ 6 (D, E, and H);
n Z 3 donors (B and G). *P < 0.05, **P < 0.01,
and ***P < 0.001.
Baker et alMitochondrial OCR Monitoring
The mitochondrial oxygen consumption rate (OCR) of
NHU cells in the presence and absence of 3 mmol/L
ketamine was assessed using an XFp Analyzer to perform
an XF Cell Mitochondrial Stress Test, according to
the manufacturer’s instructions (Seahorse Bioscience,
Copenhagen, Denmark), as detailed.11 Brieﬂy, NHU cells
were seeded at 1  104 cells per well and cultured for 48
hours to near conﬂuence, when cultures were exposed to
medium containing 3 mmol/L ketamine and maintained for a
further 48 hours. Before the assay, cultures were washed
with, and then incubated in, XF Assay modiﬁed Dulbecco’s1270modiﬁed Eagle’s medium (unbuffered; Seahorse Bioscience)
containing 5 mmol/L L-glutamine, 5 mmol/L sodium pyru-
vate, and 6 mmol/L glucose. The XFp Analyzer performed
ﬂuorimetric detection of oxygen consumption by sequentially
adding and mixing 1 mmol/L oligomycin, 1 mmol/L carbonyl
cyanide-4-(triﬂuoromethoxy)phenylhydrazone (FCCP), and
0.5 mmol/L antimycin A with 0.5 mmol/L rotenone at
deﬁned time points. Values were normalized to total
cellular protein derived from a bicinchoninic acid assay
(Pierce, supplied by Thermo Fisher Scientiﬁc), and
mitochondrial respiration was quantiﬁed by normalization
to OCR values in the presence of antimycin A and rote-
none, as described elsewhere.11ajp.amjpathol.org - The American Journal of Pathology
Figure 4 RT-PCR of NMDA receptor transcripts (GRIN isoforms). No
expression of GRIN isoforms was detected in normal (nonimmortalized)
human urothelial (NHU) cells under either proliferating or differentiated
cell culture conditions. Furthermore, no GRIN expression was detected in
freshly isolated urothelium after its separation from the underlying
stroma. Representative images of one donor (proliferating and differenti-
ated NHU) and one donor P0 urothelium are shown. Uroplakin 2 (UPK2)
transcript expression was used to conﬁrm urothelial differentiation, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was included as an
internal housekeeping control to conﬁrm RNA integrity. In addition, no
products were detected in reverse transcriptaseenegative cDNA controls
that were generated using each RNA preparation.
Ketamine-Induced Apoptosis in UrotheliumTMRM Staining and Flow Cytometry
NHU cell cultures were treated for 48 hours with either
control KSFMc or 3 mmol/L ketamine in KSFMc, washed
twice with KSFMc, and labeled with 200 nmol/L tetrame-
thylrhodamine (TMRM) methyl ester (Molecular Probes;
supplied by Thermo Fisher Scientiﬁc) in KSFMc for 30
minutes at 37C. Live cultures were imaged immediately at
ﬁxed exposures using an Olympus B60 epiﬂuorescent mi-
croscope (Southend-on-Sea, UK).
For ﬂow cytometry, the same procedure was followed,
but cells were ﬁrst harvested with trypsin in versene before
TMRM staining was performed in suspension. Staining was
quantiﬁed using a CyAn ADP analyzer (Beckman Coulter
Ltd, High Wycombe, UK), and data were summarized for
three independent donor cell lines as the mean of median
ﬂuorescence from each donor, normalized to the no keta-
mine control.
Cellular ATP Assay
Cellular ATP was quantiﬁed using the ENLITEN ATP assay,
according to the manufacturer’s instructions (Promega Ltd,
Southampton, UK), and normalized using a bicinchoninic
acid protein assay. Brieﬂy, NHU cells were cultured to
80% conﬂuence in 10 cm dishes before exposure to
3 mmol/L ketamine or medium only (KSFMc) for 48
hours. Cultures were harvested, lysed in 2% trichloro-
acetic acid, and assayed for activation of luciferase
against an ATP standard curve in a luminescence plate
reader (BMG Labtech Ltd., Aylesbury, UK).
Western Blot Analysis
Whole cell lysates were obtained from cultures by in situ
lysis in SDS electrophoresis sample buffer, containing
13 mmol/L dithiothreitol and 0.2% (v/v) protease in-
hibitors (Protease Inhibitor Cocktail set III; Calbiochem,
supplied by Merck Chemicals Ltd., Beeston, UK), after
two phosphate-buffered saline washes. Cells from at least
three donors were used in all experiments. Mitochondrial
and cytosolic fractions were prepared from all (adherent
and detached) cells using the MIT1000 kit, according to
the manufacturer’s instructions (Merck Chemicals, Ltd.).
Lysates were sonicated and microcentrifuged, and the
protein concentration was determined by Bradford
colorimetric assay. Protein samples (20 to 40 mg) were
resolved by electrophoresis of NuPAGE gels using the
Novex system (Invitrogen) and electrotransferred to pol-
yvinylidene diﬂuoride membranes (Merck Millipore).
Membranes were blocked for 1 hour in Odyssey blocking
buffer (Li-Cor Biosciences UK Ltd., Cambridge, UK),
incubated with titrated primary antibody overnight at 4C.
Primary antibodies were raised against serine 473
phosphorylated-Akt (Cell Signaling Technology Europe,
Leiden, the Netherlands; 9271, rabbit; 1:1000 dilution),The American Journal of Pathology - ajp.amjpathol.orgthreonine 202/tyrosine 204 phosphorylated-ERK1/2 (Cell
Signaling; 9101, rabbit; 1:1000 dilution), serine 9 phos-
phorylated glycogen synthase kinase (GSK) 3b (Abcam plc,
Cambridge, UK; ab30619, rabbit; 1:500 dilution), Bcl-2
(Merck Millipore; clone 100, mouse; 1:1000 dilution), cyto-
chrome c (Santa Cruz, supplied by Insight Biotechnology
Ltd., Wembley, UK; H-104, rabbit; 0.4 mg/mL), caspase 9
(Cell Signaling; 9502, rabbit; 1:1000 dilution), caspase 3
(Cell Signaling; 9662, rabbit; 1:1000 dilution) and cleaved-
poly (ADP ribose) polymerase (Cell Signaling; 5625, rab-
bit; 1:1000 dilution). Densitometry was normalized using the
intensity of housekeeping proteins b-actin (Sigma-Aldrich;
clone AC15, mouse; 1:10,000 dilution) or glyceraldehyde-3-
phosphate dehydrogenase (Merck Millipore; clone 6C5,
mouse; 1:2000 dilution). Membranes were labeled with the
appropriate IRDye-conjugated secondary antibody and visu-
alized using an Odyssey Infrared imager (Li-Cor).
Caspase 3/7 Assay
NHU cell cultures were seeded at 1.5  105 cells/well in
96-well plates (Corning Primaria, Fisher Scientiﬁc UK1271
Figure 5 Treatment of normal (nonimmortalized) human urothelial (NHU) cells with ketamine (Ket) resulted in elevation of cytosolic [Ca2þ]. A: The
addition of 1 mmol/L ketamine (noncytotoxic) to a culture of NHU cells produced a transient increase in cytosolic [Ca2þ], whereas exposure to 3 mmol/L
ketamine (cytotoxic) induced a higher [Ca2þ] in the cytoplasm, which did not return to a normal baseline. B: The role of purinergic receptors in mediating the
urothelial response to 1 mmol/L ketamine was investigated by preincubating cultures for 10 minutes in 100 mmol/L pyridoxal-phosphate-6-azophenyl-20,40-
disulfonate (PPADS; purinergic receptor inhibitor) or ARL-67156 (ecto-ATPase inhibitor). PPADS (dotted line) almost completely blocked the calcium transient
observed after addition of 1 mmol/L ketamine to NHU cells, whereas ARL-67156 (dashed line) increased both the amplitude and duration of the transient. C:
Preincubating cultures in PPADS was not sufﬁcient to inhibit the [Ca2þ] increase triggered by 3 mmol/L ketamine. All images are traces representative of
triplicate experiments.
Baker et alLtd.), and 24 hours after seeding were treated with keta-
mine in replicates of six. After 72 hours, apoptosis was
assessed with the Sensolyte active caspase 3/7 kit used
according to themanufacturer’s instructions (Anaspec; supplied
by Cambridge Bioscience, Cambridge, UK). Brieﬂy, cells were
lysed and any active capase-3/7 cleaved a quencher from the
AFC (7-amido-4-triﬂuoromethylcoumarin) ﬂuorophore to
generate bright blue ﬂuorescence. Caspase activityeassociated
ﬂuorescence was measured on a PolarStar Optima plate reader
(BMGLabTech) at excitation and emission wavelengths of 355
and 492 nm, respectively.
Statistical Analysis
Means were compared using the appropriate statistical tests in
Graphpad InStat statistical software version 3.05 (GraphPad,
La Jolla, CA), and repeated-measures analysis of variance
was performed in SPSS version 20 (IBM, Portsmouth, UK).
P < 0.05 was considered signiﬁcant.
Results
Direct Exposure of Urothelium to Ketamine
Organ cultures of human ureters from six donors were used to
examine the direct effect of ketamine exposure to the uro-
thelium (Figure 1). Hematoxylin and eosin staining of ureters
after 72 hours’ exposure to 3 mmol/L ketamine showed
thinning of the epithelium throughout the organ culture in
ﬁve of six donors (Figure 1), with pyknotic nuclei and kar-
yorrhexis evident as cells were lost from the urothelium
(Figure 1). Immunolabelling of organ cultures with a
cleaved-cytokeratin 18 antibody showed immunoreactivity
in cells being lost from the epithelium, indicating the
importance of apoptosis (Figure 1).
To examine the mechanisms of ketamine action further,
nonimmortalized NHU cell cultures were exposed to ketamine1272during a 6-day time course. Ketamine induced a reproducible
concentration-dependent effect, being growth inhibitory at
0.3 mmol/L, cytostatic at 1 mmol/L, and toxic at>1 mmol/L
(Figure 2A). Counts of proliferating NHU cell cultures after 4
days of exposure found the half-maximal inhibitory concen-
tration for ketamine to be 0.93 mmol/L (Figure 2B). On the
basis of these data, the cytostatic/half-maximal inhibitory
concentration of 1 mmol/L ketamine was used in compari-
son with a cytotoxic dose of 3 mmol/L for all further studies.
Adherent and detached NHU cells exposed to 3 mmol/L
ketamine were collectively lysed, and cytoplasmic- and
mitochondrial-enriched fractions were prepared to study the
localization of the apoptotic mediator cytochrome c. The
cytoplasmic fractions of ketamine-treated cells showed a sig-
niﬁcant mean 2.4-fold increase in cytochrome c when
compared with time-matched controls after 24 hours of
exposure (repeated-measures analysis of variance P < 0.05,
nZ 3) (Figure 3, A and B). Exposure to 3 mmol/L ketamine
caused a rapid reduction in phosphorylation of Akt (serine
473) and ERK1/2 (threonine 202/tyrosine 204), with a
consequential reduction of inhibition of GSK3b activity
(Figure 3C). The serine 9 phosphorylated form of GSK3b is
inactive, and 3 mmol/L ketamine reduced phosphorylation
(Figure 3C), indicating increased GSK3b activity that could
contribute to mitochondrial permeability transition pore acti-
vation.12 Inhibition of GSK3b with SB415286 showed a
small, but signiﬁcant, alleviation of the>1 mmol/L ketamine-
induced toxicity at 48 hours (analysis of variance with Tukey-
Kramer multiple comparisons post test P < 0.01, n Z 6)
(Figure 3D). Furthermore, inhibition of the mitochondrial
permeability transition pore with cyclosporin A showed a
signiﬁcant concentration-dependent inhibition of toxicity at 48
hours (analysis of variance with Tukey-Kramer multiple
comparisons post test P < 0.01, n Z 6) (Figure 3E).
Cotreatment of NHU cells with 3 mmol/L ketamine and
3 mmol/L cyclosporin A led to a 1.4-fold increase in cell
viability at 48 hours, compared with cells treated withajp.amjpathol.org - The American Journal of Pathology
Figure 6 Normal (nonimmortalized) human
urothelial (NHU) cell cystolic [Ca2þ] was elevated
by the release of stores from the endoplasmic re-
ticulum in response to ketamine exposure. A: The
repeated administration of 1 mmol/L ketamine to
NHU cells in the presence of 2 mmol/L extracellular
[Ca2þ] resulted in repeated transient increases in
cytosolic [Ca2þ], with no sign of reduced intensity
in subsequent transients. B: The source of the
calcium transient was elucidated by performing
repeated challenges of urothelial cells with 1
mmol/L ketamine (solid line) and 20 mmol/L ATP
(dashed line) in the absence of extracellular cal-
cium. An initial treatment with either ketamine or
ATP generated a calcium transient showing that, in
both cases, calcium was released from internal
stores. A second stimulation triggered a signiﬁ-
cantly attenuated transient in response to either
ketamine or ATP, indicating incomplete reﬁlling of
the internal stores. C: Pretreatment of urothelial
cell cultures with 100 mmol/L 2-APB produced
complete inhibition (dashed line) of the 1 mmol/L
ketamine-induced calcium release (solid line). D:
The source of the sustained [Ca2þ] elevation was
conﬁrmed as internal by stimulating the cells with
3 mmol/L ketamine in the absence of exogenous
calcium. E: Thapsigargin was used to inhibit SERCA
pumps and effectively empty the ER by allowing
Ca2þ ions to leak out. The 3 mmol/L ketamine-
induced elevation in cytosolic [Ca2þ] persisted.
Images are traces representative of triplicate
experiments.
Ketamine-Induced Apoptosis in Urotheliumketamine alone (n Z 12 measurements of cells from two
independent donors).
Exposure to 3 mmol/L ketamine for 72 hours induced
signiﬁcant increases in the abundance of caspase 9 (mean,
2.6-fold), caspase 3 (mean, 2.1-fold), and cleaved poly
(ADP-ribose) polymerase (mean, 48.5-fold), as assessed
by densitometry of Western blots (Figure 3, F and G). A
caspase 3/7 activity assay recorded signiﬁcant increases in
caspase activity detected after 72 hours with ketamine at
concentrations 3 mmol/L (Figure 3H).
NMDAR Expression by Human Urothelium
Ketamine is an NMDAR antagonist; however, pretreatment
of NHU cells with a combination of 1 mmol/L D-serine and
100 mmol/L NMDA was unable to inhibit calcium transients
or block ketamine-induced toxicity (data not shown).
The potent, speciﬁc NMDAR antagonist MK-801 (alias
dizocilpine, which has an NMDAR dissociation constant
100-fold greater than ketamine13) did not trigger any
toxicity or calcium transients at concentrations 100 mmol/L
(data not shown). The lack of any effects triggered by speciﬁc
agonists/antagonists of the NMDAR led to evaluation of
the expression of NMDAR (GRIN) isoform transcripts byThe American Journal of Pathology - ajp.amjpathol.orgproliferating and differentiated NHU cell cultures; no
expression of GRIN1, 2A, 2B, 2C, or 2D was detected
(Figure 4). To ensure that lack of GRIN transcripts was not
an artifact of culturing urothelial cells, transcript expression
was analyzed in freshly isolated urothelium, which was
removed from the underlying stroma to prevent contamina-
tion with other cell types. No expression of GRIN isoform
transcripts was detected in freshly isolated in situ human
urothelium (Figure 4).
The Role of Calcium Signaling in the NHU Cell Toxicity
of Ketamine
The cytostatic concentration of 1 mmol/L ketamine was
seen to elicit an increase in cytosolic calcium concentration
in 95% of NHU cells in culture; this transient was of
comparable intensity to that stimulated by 50 mmol/L ATP,
and all cells that responded to ATP were responsive to ke-
tamine (Figure 5A). The amplitude of the calcium transient
in response to ketamine was concentration-dependent, and
the duration was associated with the observed toxicity. In
NHU cells exposed to 1 mmol/L ketamine for 1 minute,
the calcium signal returned to baseline after an average of 90
seconds, whereas 3 mmol/L ketamine for 1 minute invoked1273
Figure 7 Ketamine exposure causes mitochondrial stress in normal
(nonimmortalized) human urothelial (NHU) cells. A: NHU cells exposed to
3 mmol/L ketamine for 48 hours had a signiﬁcantly lower resting mito-
chondrial oxygen consumption rate (OCR) than controls (54.4%; Mann-
Whitney test P < 0.001). The proportion of OCR devoted to physiology
other than ATP generation remained the same, whereas the spare mito-
chondrial capacity in control cells was far greater (4.6-fold; Mann-Whitney
test). Data are the means of experiments performed in duplicate on three
independent cell lines. B: NHU cells labeled with tetramethylrhodamine
(TMRM) showed that 3 mmol/L ketamine exposure led to elevated mito-
chondrial membrane potential (images are representative of experiments
performed in cells from three donors). C: Results in B were conﬁrmed
quantitatively by ﬂow cytometry (mean of three independent donor cell
lines given). D: Cellular ATP was signiﬁcantly reduced to 76.8% of control
after 3 mmol/L ketamine exposure for 48 hours. Data are the means of
duplicate measurements in three independent donor cell lines. Error bars
represent SD (A, C, and D). *P < 0.05, ***P < 0.001. Scale barZ 50 mm
(B). FCCP, carbonyl cyanide-4-(triﬂuoromethoxy)phenylhydrazone.
Baker et ala sustained elevation in the cytosolic calcium concentration
that remained unresolved after 10 minutes (Figure 5A).
The role of ATP in driving the observed elevations of
cytosolic calcium concentration was elucidated by cotreat-
ment of 1 mmol/L ketamine with an ecto-ATPase inhibitor
6-N,N-diethyl-D-b-g-dibromomethylene-ATP (ARL-67156),
which signiﬁcantly enhanced the amplitude and duration
of the calcium transient (Figure 5B). By contrast, pre-
treatment and coadministration of the purinergic receptor
inhibitor pyridoxal-phosphate-6-azophenyl-20,40-disulfonate
(PPADS) with 1 mmol/L ketamine almost completely abro-
gated the calcium transient (Figure 5B). Although these results
demonstrated ATP was critical to the calcium transients1274stimulated by 1 mmol/L ketamine, it was not possible with
PPADS to inhibit the nonresolving elevation of cytosolic
calcium triggered by 3 mmol/L ketamine (Figure 5C).
To understand the source and mechanism of ketamine-
induced calcium release, cultures were challenged with
1mmol/L ketamine, which, in the presence of 2 mmol/L (near-
physiological) extracellular calcium, produced repeated
calcium transients of similar intensity (Figure 6A). Although
an initial transient elevation in cytosolic calcium concentration
stimulated by 1 mmol/L ketamine was also observed in the
absence of extracellular calcium, a second challenge produced
a smaller calcium response than the ﬁrst because of incomplete
reﬁlling of calcium stores in the endoplasmic reticulum (ER)
(Figure 6B). This was similar to the effect observed on
repeatedATP stimulation in the absence of exogenous calcium
and demonstrated that the transient elevations in cytosolic
calcium concentration were derived from intracellular stores
(Figure 6B). When cultures were pretreated with the inositol
trisphosphate (IP3) receptor inhibitor 2-aminoethoxydiphenyl
borate (2-APB), in the absence of extracellular calcium, the
1 mmol/L ketamine-stimulated transient elevation in cytosolic
calcium concentration was lost, revealing the source of cal-
cium to be the ER (Figure 6C). It was not possible to inhibit the
nonresolving elevation of cytosolic calcium concentration
triggered by 3 mmol/L ketamine using 2-APB (data not
shown).
The prolonged elevation in cytosolic calcium concentration
induced by 3 mmol/L ketamine in 2 mmol/L extracellular
calcium (Figure 5A) was reproduced when cultures were
stimulated by 3 mmol/L ketamine in the absence of extracel-
lular calcium, showing this process was also driven entirely by
the release of intracellular calcium stores (Figure 6D). Using
the sarco/endoplasmic reticulum Ca2þ ATPase (SERCA)
inhibitor/ER calciumATPase inhibitor, thapsigargin, to prevent
reﬁlling of the ER (and therefore induce its emptying through
calcium ion leakage), it was observed that the 3 mmol/L
ketamine-induced elevation of cytosolic calcium concentration
persisted, suggesting this calcium was not derived from a
thapsigargin-sensitive region of the ER (Figure 6E).
PPADS, 2-APB, and BAPTA-AM [1,2-bis(o-amino-
phenoxy)ethane-N,N,N0,N0-tetraacetic acid-acetoxymethyl
ester] could not be titrated to inhibit ketamine toxicity, as
assessed by Alamar Blue reduction (data not shown).
Mitochondrial Physiology
NHU cells exposed to 3 mmol/L ketamine for 48 hours had a
signiﬁcantly lower resting mitochondrial OCR than controls
(mean, 54.4%; Mann-Whitney test P < 0.001) (Figure 7A).
The decrease in mitochondrial OCR in response to inhibition
of ATP synthase (1 mmol/L oligomycin) indicated the
proportion of OCR that related to the generation of ATP.
Subtracting the mitochondrial OCR after ATP synthase
inhibition, from the resting value, suggested control cells
used more oxygen to generate ATP (mean, 2.1-fold;
Mann-Whitney test P < 0.003) (Figure 7A). Addition ofajp.amjpathol.org - The American Journal of Pathology
Figure 8 Schematic diagram summarizing the
proposed mechanism of ketamine-induced cyto-
toxicity downstream of initial receptor activation/
inhibition and illustrating how the experiments
performed in this study support the proposed
mode-of-action. Ketamine exposure leads to ATP
release from the cells (the ATP signal could be
enhanced by preventing its breakdown with ARL-
67156), which binds to P2Y receptors [that were
effectively inhibited by pyridoxal-phosphate-6-
azophenyl-20,40-disulfonate (PPADS)]. Activation
of P2Y receptors releases inositol trisphosphate
(IP3), which binds IP3 receptor on the endoplasmic
reticulum [inhibited using 2-aminoethoxydiphenyl
borate (2-APB)] and causes release of stored Ca2þ
into the cytoplasm. Prolonged elevation of cyto-
plasmic [Ca2þ] triggers further Ca2þ release from
mitochondria, probably via the activated mito-
chondrial permeability transition pore (MPTP).
Ketamine exposure triggers a reduction in the
phosphorylated/active forms of Akt and ERK, pro-
moting an increase in glycogen synthase kinase
(GSK) 3b activity (which can be inhibited by
SB415286). Acting in concert, GSK3b activity and
sustained elevation of cytosolic [Ca2þ] activate the
MPTP (which can be inhibited by cyclosporin A),
leading to mitochondrial depolarization, release of
cytochrome c, and caspase-mediated apoptosis.
Ketamine-Induced Apoptosis in Urotheliumthe ionophore and uncoupling agent FCCP (1 mmol/L)
equalized the proton gradient across the inner mitochon-
drial membrane and deﬁned the maximum OCR for NHU
cell mitochondria (Figure 7A). The maximum mitochon-
drial OCR in control cells was signiﬁcantly greater than
for ketamine-exposed cells (mean, 4.6-fold; Mann-
Whitney U test P < 0.001).
TMRM labeling of NHU cells showed greater intensity in
cultures exposed to 3 mmol/L ketamine for 48 hours, indicating
that mitochondria became hyperpolarized (Figure 7, B and C).
A combination of low mitochondrial OCR with high mito-
chondrial membrane potential suggested ketamine-exposed
cells consumed ATP and used ATP synthase to maintain the
proton gradient. Cellular ATP assays showed that ATP was
signiﬁcantly depleted after 48 hours of exposure to 3 mmol/L
ketamine (76.8% of control cells; t-test with Welch correction
P < 0.05) (Figure 7D).Discussion
The data reported herein suggest that ketamine-induced toxicity
to urothelial cells is associated with prolonged elevation of
cytosolic calcium concentration triggered by high concentra-
tions of ketamine (>1 mmol/L). High and sustained intracel-
lular calcium ion concentrations can lead tomitochondrial stress
and ultimately cytochrome c release, which causes caspase
activation and apoptosis.14 The role of apoptosis in ketamine-
induced cystitis was supported using human urothelial organ
cultures that showed pyknotic nuclei, karyorrhexis, and
immunoreactivity with a cleaved-cytokeratin 18 antibody.The American Journal of Pathology - ajp.amjpathol.orgOur study demonstrates, for the ﬁrst time, that ketamine
induces an increase in cytosolic calcium concentration in
urothelial cells via release of calcium from internal stores
rather than inﬂux from the extracellular milieu, suggesting
disruption of organelle function. The observation that
ketamine-induced calcium transients were blocked with
2-APB conﬁrmed that the ketamine-induced calcium
response was because of an IP3-mediated calcium release
from the ER. Exacerbation of calcium transients by inhib-
iting ecto-ATPases (with ARL-67156) and abrogation after
P2Y inhibition (by PPADS) suggest that ketamine stimu-
lates ATP release from urothelial cells, which then binds
purinergic receptors on the cell surface, allowing IP3 to
trigger calcium release from the ER. The purinergic re-
ceptors involved in this process are almost certain to be of
the P2Y family (known to be functional in human urothe-
lium15) because P2X receptors act as channels, allowing
extracellular calcium into the cytoplasm, and the ketamine-
induced calcium release observed persisted in the absence of
extracellular calcium. This proposed P2Y-mediated action
of ketamine (Figure 8) is supported by similar ﬁndings in a
rat microglial cell line,16 which is the only other report of
intracellular calcium transients triggered by ketamine.
The source of calcium that delivers the sustained elevation
observed during 3 mmol/L ketamine exposure remains elusive;
however, others have reported thapsigargin-insensitive stores of
calcium in the Golgi and high concentrations of calcium ions in
some regions of the ER.17 In addition, it has been reported that
thapsigargin-insensitive calcium stores cannot be mobilized by
IP3-release (as triggered by 1 mmol/L ketamine), which might
suggest the extra calcium released by 3 mmol/L ketamine is1275
Baker et alaccessed via a different mechanism.18 Intense TMRM labeling
of ketamine-exposed cells suggests the mitochondria in most
adherent cells retain their membrane potential and, therefore,
are unlikely to be the source of the global increase in cytosolic
calcium concentration.
The mitochondria of ketamine-exposed urothelial cells
displayed extremely low OCR, with only slight inhibition
by oligomycin (suggesting little ATP generation) and no
detectable increase after FCCP addition (demonstrating a
lack of spare capacity for ATP generation). These data
support the concept that the electron transport chain is
largely inactive in the mitochondria of ketamine-exposed
cells and, combined with intense TMRM labeling (showing
the inner mitochondrial membranes were hyperpolarized),
suggest that the mitochondria had become ATP consumers.
By running ATP synthase in reverse, mitochondria can
maintain membrane potential and survive stressors that
inhibit functioning of the electron transport chain.19 The
depletion of cellular ATP in ketamine-exposed cells pro-
vides additional support for their inhibited bioenergetics. At
a certain threshold, individual mitochondria will run out of
ATP, membrane potential will no longer be maintained by
ATP synthase, and the mitochondrial permeability transition
pore will form, releasing cytochrome c and activating cas-
pases (including 9 and 3) to initiate apoptosis. The
involvement of mitochondria in caspase activation in
response to ketamine by human lymphocytes and neuronal
cells was previously reported,20 and is an established mech-
anism of toxicity for other xenobiotics in the urothelium.21
Studies of cultured rat6 and monkey7 cortical neurons
identiﬁed the NMDAR as the mediator of ketamine-induced
apoptosis in these cells. By contrast, our study found no
expression of GRIN transcripts and no response to NMDAR
agonists or more speciﬁc antagonists by human urothelial
cells in vitro or in situ. Notably, previous reports of NMDAR
expression in human and rat urinary tract tested homogenized
urothelial/stromal tissue together.8 In a study of human
lymphocytes and neuronal cells, the low stereospeciﬁcity of
ketamine-induced apoptosis was taken as evidence against
the involvement of NMDAR, which has a higher afﬁnity for
S-ketamine,20 suggesting that the signiﬁcance of non-
NMDAR targets of ketamine may not be conﬁned to the
urothelium. The initial receptor responsible for stimulating
the ATP release remains elusive and is particularly difﬁcult to
identify because of the recognized receptor-binding pro-
miscuity of ketamine.
We previously reported nerve hyperplasia present in
ketamine cystitis patients, which might play a role in pain
generation.5 Herein, we report urothelial ATP release in
response to ketamine exposure, which may be another factor
in the extreme pain experienced, because ATP acting on
afferent nerves in the bladder wall is a widely accepted
cause of pelvic pain.22
Recreational ketamine consumption tends to be orders of
magnitude higher (54% of users have taken >1 g in a ses-
sion23) than in the low (50 mg) oral dose clinical studies on1276which predicted urine concentrations are based.24 A young
adult male taking 1 g of ketamine could expect 85% of the
drug to be excreted in the urine within 24 hours,24 and
taking into account the average voiding rate of 6  300 mL
per day,25 a urine concentration in excess of 1 mmol/L is
theoretically possible, suggesting the scale of in vitro
toxicity reported herein (and by others in cancer cell lines26)
is relevant clinically. Formal support would require accurate
quantiﬁcation of ketamine/metabolite concentrations in the
urine of symptomatic recreational users. Nevertheless,
our biological observation of a sustained, calcium-induced,
intrinsic apoptotic pathwayedriven response that may
drive extensive urothelial tissue damage, resulting in
chronic inﬂammation, provides valuable clues to explain the
reported pathology associated with ketamine cystitis.
Moreover, in light of the recent drive by the pharmaceutical
sector to produce new-generation ketamine derivatives for
clinical use as novel antidepressants,27 this model of bladder
cells will be valuable in ensuring that any urological effects
are identiﬁed and closely monitored.Acknowledgments
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